{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:03:35Z","timestamp":1777489415895,"version":"3.51.4"},"reference-count":127,"publisher":"Elsevier","isbn-type":[{"value":"9780128200025","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.pmbts.2020.08.006","type":"book-chapter","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T08:43:50Z","timestamp":1599813830000},"page":"121-145","source":"Crossref","is-referenced-by-count":6,"title":["Strain variation in treatment and prevention of human prion diseases"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2020.08.006_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0368-1742(61)80013-1","article-title":"Scrapie produced experimentally in goats with special reference to the clinical syndrome","volume":"71","author":"Pattison","year":"1961","journal-title":"J Comp Pathol"},{"issue":"Pt. 3","key":"10.1016\/bs.pmbts.2020.08.006_bb0015","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-72-3-595","article-title":"The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis","volume":"72","author":"Bruce","year":"1991","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0021-9975(73)90024-8","article-title":"Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation","volume":"83","author":"Fraser","year":"1973","journal-title":"J Comp Pathol"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0025","first-page":"263","article-title":"Strain typing of prion diseases using in vivo mouse models","volume":"2017","author":"Boyle","year":"1658","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0030","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1128\/jvi.66.4.2096-2101.1992","article-title":"Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent","volume":"66","author":"Bessen","year":"1992","journal-title":"J Virol"},{"issue":"48","key":"10.1016\/bs.pmbts.2020.08.006_bb0035","doi-asserted-by":"crossref","first-page":"32230","DOI":"10.1074\/jbc.273.48.32230","article-title":"Strain-dependent differences in beta-sheet conformations of abnormal prion protein","volume":"273","author":"Caughey","year":"1998","journal-title":"J Biol Chem"},{"issue":"6650","key":"10.1016\/bs.pmbts.2020.08.006_bb0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"issue":"6602","key":"10.1016\/bs.pmbts.2020.08.006_bb0050","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/383685a0","article-title":"Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD","volume":"383","author":"Collinge","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"issue":"44","key":"10.1016\/bs.pmbts.2020.08.006_bb0060","doi-asserted-by":"crossref","first-page":"40377","DOI":"10.1074\/jbc.C100458200","article-title":"pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease","volume":"276","author":"Zanusso","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/9030","article-title":"Strain-specific prion-protein conformation determined by metal ions","volume":"1","author":"Wadsworth","year":"1999","journal-title":"Nat Cell Biol"},{"issue":"Pt. 6","key":"10.1016\/bs.pmbts.2020.08.006_bb0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/brain\/awg125","article-title":"Molecular classification of sporadic Creutzfeldt-Jakob disease","volume":"126","author":"Hill","year":"2003","journal-title":"Brain"},{"issue":"5295","key":"10.1016\/bs.pmbts.2020.08.006_bb0075","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.274.5295.2079","article-title":"Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity","volume":"274","author":"Telling","year":"1996","journal-title":"Science"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.08.006_bb0080","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.biocel.2008.05.024","article-title":"Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture","volume":"40","author":"Lawson","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ana.410050616","article-title":"Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents","volume":"5","author":"Tateishi","year":"1979","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0034-5288(18)34031-1","article-title":"Inoculation of voles, Chinese hamsters, gerbils and guinea-pigs with scrapie brain material","volume":"13","author":"Chandler","year":"1972","journal-title":"Res Vet Sci"},{"issue":"Pt. 2","key":"10.1016\/bs.pmbts.2020.08.006_bb0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/0022-1317-73-2-329","article-title":"Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters","volume":"73","author":"Bessen","year":"1992","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/bs.pmbts.2020.08.006_bb0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM198205273062107","article-title":"Chemical disinfection of Creutzfeldt-Jakob disease virus","volume":"306","author":"Brown","year":"1982","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.brainresbull.2005.09.010","article-title":"Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease","volume":"68","author":"Brazier","year":"2006","journal-title":"Brain Res Bull"},{"issue":"Pt. 8","key":"10.1016\/bs.pmbts.2020.08.006_bb0110","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1099\/0022-1317-70-8-2017","article-title":"The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice","volume":"70","author":"Kimberlin","year":"1989","journal-title":"J Gen Virol"},{"issue":"4542","key":"10.1016\/bs.pmbts.2020.08.006_bb0115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41551-019-0349-8","article-title":"A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaques","volume":"3","author":"Yamaguchi","year":"2019","journal-title":"Nat Biomed Eng"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","article-title":"Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice","volume":"53","author":"Mallucci","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1871526510909010081","article-title":"Recent advances in prion chemotherapeutics","volume":"9","author":"Sim","year":"2009","journal-title":"Infect Disord Drug Targets"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.08.006_bb0135","doi-asserted-by":"crossref","first-page":"22718","DOI":"10.3390\/molecules201219865","article-title":"Unfolded protein response and macroautophagy in Alzheimer's, Parkinson's and prion diseases","volume":"20","author":"Milisav","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0140","first-page":"227","article-title":"Quantitative traits of prion strains are enciphered in the conformation of the prion protein","volume":"16","author":"Safar","year":"2000","journal-title":"Arch Virol Suppl"},{"issue":"37","key":"10.1016\/bs.pmbts.2020.08.006_bb0145","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/bi200950v","article-title":"Relationship between conformational stability and amplification efficiency of prions","volume":"50","author":"Gonzalez-Montalban","year":"2011","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.freeradbiomed.2008.04.006","article-title":"A manganese-superoxide dismutase\/catalase mimetic extends survival in a mouse model of human prion disease","volume":"45","author":"Brazier","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003113","article-title":"Behavior of prions in the environment: implications for prion biology","volume":"9","author":"Bartelt-Hunt","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21775\/cimb.036.023","article-title":"Inactivation methods for prions","volume":"36","author":"Sakudo","year":"2020","journal-title":"Curr Issues Mol Biol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.08.006_bb0165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrP(Sc) molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0170","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1110\/ps.39201","article-title":"Strain-specified relative conformational stability of the scrapie prion protein","volume":"10","author":"Peretz","year":"2001","journal-title":"Protein Sci"},{"issue":"22","key":"10.1016\/bs.pmbts.2020.08.006_bb0175","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1128\/JVI.01057-10","article-title":"Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay","volume":"84","author":"Choi","year":"2010","journal-title":"J Virol"},{"issue":"Pt. 10","key":"10.1016\/bs.pmbts.2020.08.006_bb0180","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1099\/vir.0.82961-0","article-title":"Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain","volume":"88","author":"Lawson","year":"2007","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF03402129","article-title":"Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains","volume":"5","author":"Kuczius","year":"1999","journal-title":"Mol Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.08.006_bb0190","doi-asserted-by":"crossref","first-page":"9032","DOI":"10.1128\/jvi.71.12.9032-9044.1997","article-title":"Propagation of prion strains through specific conformers of the prion protein","volume":"71","author":"Scott","year":"1997","journal-title":"J Virol"},{"issue":"47","key":"10.1016\/bs.pmbts.2020.08.006_bb0195","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/vr.77.47.1388","article-title":"Scrapie in the welsh mountain breed of sheep and its experimental transmission to goats","volume":"77","author":"Pattison","year":"1965","journal-title":"Vet Rec"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0200","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/infdis\/145.2.683","article-title":"Effect of chemicals, heat, and histopathologic processing on high-infectivity hamster-adapted scrapie virus","volume":"145","author":"Brown","year":"1982","journal-title":"J Infect Dis"},{"issue":"8009","key":"10.1016\/bs.pmbts.2020.08.006_bb0205","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(77)91958-4","article-title":"Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery","volume":"1","author":"Bernoulli","year":"1977","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0210","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp.57.6.757","article-title":"Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery","volume":"57","author":"Gibbs","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0022-510X(83)90021-7","article-title":"Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents","volume":"59","author":"Kimberlin","year":"1983","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1348-0421.1991.tb01544.x","article-title":"Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen","volume":"35","author":"Tateishi","year":"1991","journal-title":"Microbiol Immunol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0225","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0166-0934(93)90126-C","article-title":"Comparative analysis of scrapie agent inactivation methods","volume":"41","author":"Ernst","year":"1993","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.410240325","article-title":"Inactivation of the Creutzfeldt-Jakob disease agent","volume":"24","author":"Tateishi","year":"1988","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.410240326","article-title":"Inactivation of the Creutzfeldt-Jakob disease agent","volume":"24","author":"Tamai","year":"1988","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.08.006_bb0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM198403153101122","article-title":"Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus","volume":"310","author":"Brown","year":"1984","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0245","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2105\/AJPH.73.6.661","article-title":"Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease","volume":"73","author":"Walker","year":"1983","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0250","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/infdis\/153.6.1145","article-title":"Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue","volume":"153","author":"Brown","year":"1986","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.08.006_bb0255","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/BF03401958","article-title":"Transmission of scrapie by steel-surface-bound prions","volume":"7","author":"Flechsig","year":"2001","journal-title":"Mol Med"},{"issue":"Pt. 3","key":"10.1016\/bs.pmbts.2020.08.006_bb0260","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1099\/vir.0.80484-0","article-title":"An enzyme-detergent method for effective prion decontamination of surgical steel","volume":"86","author":"Jackson","year":"2005","journal-title":"J Gen Virol"},{"issue":"Pt. 12","key":"10.1016\/bs.pmbts.2020.08.006_bb0265","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1099\/vir.0.80346-0","article-title":"Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces","volume":"85","author":"Lemmer","year":"2004","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0270","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/502392","article-title":"Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies","volume":"25","author":"Yan","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0275","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/JVI.80.1.322-331.2006","article-title":"Inactivation of prions by acidic sodium dodecyl sulfate","volume":"80","author":"Peretz","year":"2006","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/bs.pmbts.2020.08.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.08.006_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005914","article-title":"Inactivation of prions and amyloid seeds with hypochlorous acid","volume":"12","author":"Hughson","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0290","doi-asserted-by":"crossref","first-page":"24993","DOI":"10.1038\/srep24993","article-title":"A direct assessment of human prion adhered to steel wire using real-time quaking-induced conversion","volume":"6","author":"Mori","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146833","article-title":"Rapid and highly sensitive detection of variant Creutzfeldt-Jakob disease abnormal prion protein on steel surfaces by protein misfolding cyclic amplification: application to prion decontamination studies","volume":"11","author":"Belondrade","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0300","doi-asserted-by":"crossref","first-page":"a024430","DOI":"10.1101\/cshperspect.a024430","article-title":"Insights from therapeutic studies for PrP prion disease","volume":"7","author":"Teruya","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"17","key":"10.1016\/bs.pmbts.2020.08.006_bb0305","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1073\/pnas.161274798","article-title":"Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease","volume":"98","author":"Korth","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.10336","article-title":"Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model","volume":"52","author":"Collins","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0315","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0706072","article-title":"A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie","volume":"144","author":"Gayrard","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.08.006_bb0320","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/JVI.78.10.4999-5006.2004","article-title":"Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models","volume":"78","author":"Doh-ura","year":"2004","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/bs.pmbts.2020.08.006_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000673","article-title":"Continuous quinacrine treatment results in the formation of drug-resistant prions","volume":"5","author":"Ghaemmaghami","year":"2009","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0330","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000076350","article-title":"Results of quinacrine administration to patients with Creutzfeldt-Jakob disease","volume":"17","author":"Nakajima","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0335","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.wnf.0000134853.36429.0e","article-title":"Combined quinacrine and chlorpromazine therapy in fatal familial insomnia","volume":"27","author":"Benito-Leon","year":"2004","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0340","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S1474-4422(09)70049-3","article-title":"Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial","volume":"8","author":"Collinge","year":"2009","journal-title":"Lancet Neurol"},{"issue":"23","key":"10.1016\/bs.pmbts.2020.08.006_bb0345","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.0b013e3182a9f3b4","article-title":"Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease","volume":"81","author":"Geschwind","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.08.006_bb0350","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1128\/jvi.74.10.4894-4897.2000","article-title":"Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation","volume":"74","author":"Doh-Ura","year":"2000","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.08.006_bb0355","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.ejmech.2011.04.016","article-title":"Anti-prion activities and drug-like potential of functionalized quinacrine analogs with basic phenyl residues at the 9-amino position","volume":"46","author":"Nguyen","year":"2011","journal-title":"Eur J Med Chem"},{"issue":"14","key":"10.1016\/bs.pmbts.2020.08.006_bb0360","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1016\/j.bmc.2008.05.060","article-title":"Antiprion activity of functionalized 9-aminoacridines related to quinacrine","volume":"16","author":"Nguyen","year":"2008","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0365","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nbd.2003.09.006","article-title":"Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Ca(v) 2.2) which is ameliorated by quinacrine treatment","volume":"15","author":"Sandberg","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0370","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13506120410001689634","article-title":"Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPSc replication in vitro","volume":"11","author":"Kishida","year":"2004","journal-title":"Amyloid"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0375","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.LAB.0000074919.08232.A2","article-title":"Differential inhibition of prion propagation by enantiomers of quinacrine","volume":"83","author":"Ryou","year":"2003","journal-title":"Lab Investig"},{"issue":"22","key":"10.1016\/bs.pmbts.2020.08.006_bb0380","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1021\/jm060773j","article-title":"A chimeric ligand approach leading to potent antiprion active acridine derivatives: design, synthesis, and biological investigations","volume":"49","author":"Dollinger","year":"2006","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/bs.pmbts.2020.08.006_bb0385","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1073\/pnas.1322377111","article-title":"Quinacrine promotes replication and conformational mutation of chronic wasting disease prions","volume":"111","author":"Bian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/bs.pmbts.2020.08.006_bb0390","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1128\/JVI.77.15.8462-8469.2003","article-title":"Evaluation of quinacrine treatment for prion diseases","volume":"77","author":"Barret","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0395","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1074\/jbc.M411439200","article-title":"Altered interaction and expression of proteins involved in neurosecretion in scrapie-infected GT1-1 cells","volume":"280","author":"Sandberg","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-5-29","article-title":"Aberrant ERK 1\/2 complex activation and localization in scrapie-infected GT1-1 cells","volume":"5","author":"Didonna","year":"2010","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0405","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1471-4159.2007.05140.x","article-title":"Gene expression profile of quinacrine-cured prion-infected mouse neuronal cells","volume":"105","author":"Fasano","year":"2008","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0410","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/NEN.0b013e3182544680","article-title":"A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases","volume":"71","author":"Bajsarowicz","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5\u20136","key":"10.1016\/bs.pmbts.2020.08.006_bb0415","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/19336896.2018.1525254","article-title":"A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds","volume":"12","author":"Ladner-Keay","year":"2018","journal-title":"Prion"},{"key":"10.1016\/bs.pmbts.2020.08.006_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2014.12.014","article-title":"Prion protein-coated magnetic beads: synthesis, characterization and development of a new ligands screening method","volume":"1379","author":"de Moraes","year":"2015","journal-title":"J Chromatogr A"},{"issue":"30","key":"10.1016\/bs.pmbts.2020.08.006_bb0425","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.0803671105","article-title":"A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains","volume":"105","author":"Spilman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0430","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12640-010-9189-8","article-title":"Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity","volume":"19","author":"Villa","year":"2011","journal-title":"Neurotox Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0435","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/jnr.10849","article-title":"Quinacrine blocks PrP (106-126)-formed channels","volume":"74","author":"Farrelly","year":"2003","journal-title":"J Neurosci Res"},{"issue":"13","key":"10.1016\/bs.pmbts.2020.08.006_bb0440","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/00001756-200309150-00017","article-title":"Quinacrine acts as an antioxidant and reduces the toxicity of the prion peptide PrP106-126","volume":"14","author":"Turnbull","year":"2003","journal-title":"Neuroreport"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.08.006_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007214","article-title":"Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species","volume":"14","author":"Foliaki","year":"2018","journal-title":"PLoS Pathog"},{"issue":"Pt. 8","key":"10.1016\/bs.pmbts.2020.08.006_bb0450","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1099\/0022-1317-65-8-1325","article-title":"Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen","volume":"65","author":"Ehlers","year":"1984","journal-title":"J Gen Virol"},{"issue":"Pt. 2","key":"10.1016\/bs.pmbts.2020.08.006_bb0455","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1099\/0022-1317-72-2-457","article-title":"Chemoprophylaxis of scrapie in mice","volume":"72","author":"Diringer","year":"1991","journal-title":"J Gen Virol"},{"issue":"Pt. 3","key":"10.1016\/bs.pmbts.2020.08.006_bb0460","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1099\/0022-1317-73-3-661","article-title":"Sulphate polyanions prolong the incubation period of scrapie-infected hamsters","volume":"73","author":"Ladogana","year":"1992","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0465","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/AAC.50.2.759-761.2006","article-title":"A porphyrin increases survival time of mice after intracerebral prion infection","volume":"50","author":"Kocisko","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"9147","key":"10.1016\/bs.pmbts.2020.08.006_bb0470","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(98)05395-1","article-title":"Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies","volume":"353","author":"Farquhar","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/bs.pmbts.2020.08.006_bb0475","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jnnp-2013-305590","article-title":"Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate","volume":"85","author":"Newman","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0480","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1440-1789.2011.01245.x","article-title":"Protease-resistant PrP and PrP oligomers in the brain in human prion diseases after intraventricular pentosan polysulfate infusion","volume":"32","author":"Honda","year":"2012","journal-title":"Neuropathology"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0404.2009.01272.x","article-title":"Less protease-resistant PrP in a patient with sporadic CJD treated with intraventricular pentosan polysulphate","volume":"121","author":"Terada","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0490","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1789.2009.01058.x","article-title":"Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases","volume":"29","author":"Tsuboi","year":"2009","journal-title":"Neuropathology"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0495","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1468-1331.2008.02108.x","article-title":"Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK","volume":"15","author":"Bone","year":"2008","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0500","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2004.07.015","article-title":"Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease","volume":"50","author":"Todd","year":"2005","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/bs.pmbts.2020.08.006_bb0505","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00701-006-0772-y","article-title":"Unsuccessful intraventricular pentosan polysulphate treatment of variant Creutzfeldt-Jakob disease","volume":"148","author":"Whittle","year":"2006","journal-title":"Acta Neurochir"},{"issue":"10","key":"10.1016\/bs.pmbts.2020.08.006_bb0510","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.00715-06","article-title":"Enhanced antiscrapie effect using combination drug treatment","volume":"50","author":"Kocisko","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt. 3","key":"10.1016\/bs.pmbts.2020.08.006_bb0515","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1099\/vir.0.82286-0","article-title":"Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases","volume":"88","author":"Larramendy-Gozalo","year":"2007","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0520","doi-asserted-by":"crossref","first-page":"530","DOI":"10.7589\/0090-3558-48.2.530","article-title":"Assessment of prospective preventive therapies for chronic wasting disease in mule deer","volume":"48","author":"Wolfe","year":"2012","journal-title":"J Wildl Dis"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0525","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.80.2.596-604.2006","article-title":"Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease","volume":"80","author":"Raymond","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0530","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2003.10.150","article-title":"Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis","volume":"312","author":"Schonberger","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0535","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2005.06.053","article-title":"Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie","volume":"388","author":"Kocisko","year":"2005","journal-title":"Neurosci Lett"},{"issue":"13","key":"10.1016\/bs.pmbts.2020.08.006_bb0540","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/20.13.3351","article-title":"Scrapie strains maintain biological phenotypes on propagation in a cell line in culture","volume":"20","author":"Birkett","year":"2001","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/bs.pmbts.2020.08.006_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106516","article-title":"Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells","volume":"9","author":"Yamasaki","year":"2014","journal-title":"PLoS One"},{"issue":"50","key":"10.1016\/bs.pmbts.2020.08.006_bb0550","doi-asserted-by":"crossref","first-page":"30221","DOI":"10.1074\/jbc.270.50.30221","article-title":"Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells","volume":"270","author":"Shyng","year":"1995","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0555","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/505914","article-title":"The 37-kDa\/67-kDa laminin receptor acts as a receptor for infectious prions and is inhibited by polysulfated glycanes","volume":"194","author":"Gauczynski","year":"2006","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/bs.pmbts.2020.08.006_bb0560","doi-asserted-by":"crossref","first-page":"17062","DOI":"10.1074\/jbc.M500122200","article-title":"Heparan sulfate is a cellular receptor for purified infectious prions","volume":"280","author":"Horonchik","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0565","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neulet.2011.04.072","article-title":"Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease","volume":"498","author":"Yokoyama","year":"2011","journal-title":"Neurosci Lett"},{"issue":"17","key":"10.1016\/bs.pmbts.2020.08.006_bb0570","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1097\/00001756-200011270-00064","article-title":"PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C)","volume":"11","author":"Deli","year":"2000","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2020.08.006_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(97)00152-8","article-title":"Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases","volume":"101","author":"Perovic","year":"1998","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/bs.pmbts.2020.08.006_bb0580","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/neur.1995.0044","article-title":"Flupirtine partially prevents neuronal injury induced by prion protein fragment and lead acetate","volume":"4","author":"Perovic","year":"1995","journal-title":"Neurodegeneration"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0585","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1006\/exnr.1997.6559","article-title":"Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126)","volume":"147","author":"Perovic","year":"1997","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0590","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0595","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1471-4159.1992.tb09437.x","article-title":"Potent inhibition of scrapie-associated PrP accumulation by congo red","volume":"59","author":"Caughey","year":"1992","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/bs.pmbts.2020.08.006_bb0600","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/jvi.69.1.506-508.1995","article-title":"Congo red prolongs the incubation period in scrapie-infected hamsters","volume":"69","author":"Ingrosso","year":"1995","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/bs.pmbts.2020.08.006_bb0605","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J Mol Biol"},{"issue":"16","key":"10.1016\/bs.pmbts.2020.08.006_bb0610","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.08.006_bb0615","first-page":"2507","article-title":"Doxorubicin and congo red effectiveness on prion infectivity in golden Syrian hamster","volume":"29","author":"Corato","year":"2009","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2020.08.006_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0625","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Haik","year":"2014","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/bs.pmbts.2020.08.006_bb0630","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jit623","article-title":"Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific","volume":"209","author":"Hannaoui","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/bs.pmbts.2020.08.006_bb0635","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/19336896.2015.1027857","article-title":"Preventive study in subjects at risk of fatal familial insomnia: innovative approach to rare diseases","volume":"9","author":"Forloni","year":"2015","journal-title":"Prion"},{"issue":"9154","key":"10.1016\/bs.pmbts.2020.08.006_bb0640","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(98)08138-0","article-title":"Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study","volume":"353","author":"Collins","year":"1999","journal-title":"Lancet"}],"container-title":["Progress in Molecular Biology and Translational Science","Prions and Neurodegenerative Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117320301216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:02:15Z","timestamp":1761796935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117320301216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128200025"],"references-count":127,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2020.08.006","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}